Summary
Procter & Gamble (PG) reported its first quarter results for fiscal year 2001, ending September 30, 2001. Net sales decreased slightly to $9.77 billion from $9.97 billion in the prior year period. Net earnings were $1.10 billion, or $0.79 per diluted share, down from $1.16 billion, or $0.82 per diluted share, in the prior year. This decline was largely impacted by a $238 million after-tax restructuring charge related to the company's "Organization 2005" initiative. Excluding restructuring charges and prior period goodwill amortization, "core" net earnings were $1.34 billion, or $0.96 per diluted share, demonstrating underlying operational strength. The company saw significant growth in its Health Care segment, driven by oral care, pet nutrition, and pharmaceuticals, with notable contributions from the Spinbrush and Whitestrips products. The adoption of new accounting standards (SFAS No. 141 and 142) starting July 1, 2001, eliminated goodwill amortization, positively impacting future earnings and shifting the focus to annual impairment testing.
Key Highlights
- 1Net sales for the quarter were $9.77 billion, a slight decrease from $9.97 billion in the prior year, impacted by foreign exchange and divestitures in certain segments.
- 2Net earnings were $1.10 billion ($0.79 per diluted share), down from $1.16 billion ($0.82 per diluted share) due to a significant $238 million after-tax restructuring charge.
- 3Excluding restructuring charges and prior period goodwill amortization, core net earnings were $1.34 billion ($0.96 per diluted share), indicating strong underlying performance.
- 4The Health Care segment showed robust growth, with net sales up 21% and net earnings up 73%, driven by oral care, pet nutrition, and pharmaceuticals, including new product contributions like Spinbrush and Whitestrips.
- 5Effective July 1, 2001, PG adopted SFAS No. 141 and 142, eliminating goodwill amortization and shifting to annual impairment testing, which will positively impact future reported earnings.
- 6Cash flow from operations remained strong at $1.3 billion, an increase from $1.1 billion in the prior year, driven by improvements in working capital.
- 7The company is actively managing its portfolio, with divestitures impacting some segments (e.g., Fabric & Home Care, Beauty Care) while others show strong growth (e.g., Health Care).